← 返回

The time has come for a prospective randomized trial to evaluate the safety of Class Ic drugs in patients with coronary artery disease.

期刊: Heart rhythm 日期: 2026-05-08 PMID: 42107681 浏览: 32
作者: Rosseel Thomas, De Potter Tom, Heidbüchel Hein, Vandenberk Bert, Ector Joris
Thomas, R., Tom, D.P., Hein, H., Bert, V., & Joris, E. (2026). The time has come for a prospective randomized trial to evaluate the safety of Class Ic drugs in patients with coronary artery disease.. Heart rhythm.
Thomas R, Tom DP, Hein H, Bert V, Joris E. The time has come for a prospective randomized trial to evaluate the safety of Class Ic drugs in patients with coronary artery disease.. Heart rhythm. 2026; PMID: 42107681
Thomas R, Tom DP, Hein H, et al. The time has come for a prospective randomized trial to evaluate the safety of Class Ic drugs in patients with coronary artery disease.[J]. Heart rhythm. 2026.
@article{thomas2026,
  author = {Rosseel Thomas and De Potter Tom and Heidbüchel Hein and Vandenberk Bert and Ector Joris},
  title = {The time has come for a prospective randomized trial to evaluate the safety of Class Ic drugs in patients with coronary artery disease.},
  journal = {Heart rhythm},
  year = {2026},
  note = {PMID: 42107681},
}
TY  - JOUR
AU  - Rosseel Thomas
AU  - De Potter Tom
AU  - Heidbüchel Hein
AU  - Vandenberk Bert
AU  - Ector Joris
TI  - The time has come for a prospective randomized trial to evaluate the safety of Class Ic drugs in patients with coronary artery disease.
T2  - Heart rhythm
PY  - 2026
AN  - PMID:42107681
ER  - 

摘要

AI 智能解读

相关文献

返回分类: 心血管
已选择 0 篇文献